FRAMINGHAM (09/24/2003) - Vertex Pharmaceuticals Inc. has named Peter Mueller chief scientific officer and senior vice president of drug discovery and innovation. Mueller joins Vertex from Boehringer Ingelheim Pharmaceuticals. Vicki L. Sato, president of Vertex, said in a press release, "The combination of Peter's scientific passion and management expertise represents an ideal phenotype to lead our global research organization and work closely with Vertex's development group to translate great science into clinically meaningful new drugs."
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.